Relation of fibrinolytic potentiation by estrogen to coagulation pathway activation in postmenopausal women
- 1 February 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (3) , 466-469
- https://doi.org/10.1016/s0002-9149(98)00891-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal WomenNew England Journal of Medicine, 1997
- Fibrinolytic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients With Angina PectorisCirculation, 1996
- Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogensThe Lancet, 1996
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996
- Association Between Increased Estrogen Status and Increased Fibrinolytic Potential in the Framingham Offspring StudyCirculation, 1995
- Association of Fibrinolytic Parameters With Early AtherosclerosisCirculation, 1995
- Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987